Unlimited blood supply company doubles stock price
Biotime the company that will have use of the unlimited disease free stem cell blood supply patent has had a stock price increase of over 100% since the blood supply news. Biotime is now worth over 41 million dollars BioTime is at $1.75 as of Aug 29, 2008 10AM PST. Michael West, BioTime’s CEO, said …